Hepatic Safety of Febuxostat and Allopurinol for Gout Patients: A Systematic Review of Randomized Controlled Trial
C Dewi, F Puspita, IM Puspitasari… - Therapeutics and Clinical …, 2023 - Taylor & Francis
Purpose This study aims to systematically review the hepatic safety of febuxostat and
allopurinol in adult gout patients. Methods We searched for information using the following …
allopurinol in adult gout patients. Methods We searched for information using the following …
[HTML][HTML] Implementing HLA-B* 58: 01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors' and patients' perspective
Introduction Allopurinol, the first-line treatment for chronic gout, is a common causative drug
for severe cutaneous adverse reactions (SCAR). HLA-B* 58: 01 allele was strongly …
for severe cutaneous adverse reactions (SCAR). HLA-B* 58: 01 allele was strongly …
[HTML][HTML] A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction …
Background: Over the past few years, studies have increasingly focused on the development
of mobile apps as complementary tools to existing traditional pharmacovigilance …
of mobile apps as complementary tools to existing traditional pharmacovigilance …
[HTML][HTML] Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
KC Dodd, R Ahmed, P Ambrose, JKL Holt… - Neuromuscular …, 2024 - Elsevier
Azathioprine is recommended as the first-line steroid-sparing immunosuppressive agent for
myasthenia gravis. Mycophenolate and methotrexate are often considered as second-line …
myasthenia gravis. Mycophenolate and methotrexate are often considered as second-line …